iDEL Therapeutics vs Infinimmune
iDEL Therapeutics vs Infinimmune, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: iDEL Therapeutics is on 45/100 and Infinimmune on 60/100.
Where each one leads
iDEL Therapeutics
Leads on none of the measures we hold for both companies.
Infinimmune
- our overall score: 60/100 against 45/100
- agent readiness: 42/100 against 32/100
- domain rating: 20/100 against 10/100
- funding raised: $75.0M against $9.7M
At a glance
| Measure | iDEL Therapeutics | Infinimmune |
|---|---|---|
| What it is | Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells. | Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms. |
| Category | Biotechnology, Pharmaceuticals, Oncology, Drug Delivery | Biotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2025 | 2017 |
| Headquarters | Dortmund, Germany | Alameda, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | iDEL Therapeutics | Infinimmune |
|---|---|---|
| Employees | Not published | 22 |
| Total funding | $9.7M | $75.0M |
| Latest round | Seed | Series A |
| LinkedIn followers | Not published | 4,055 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | iDEL Therapeutics | Infinimmune |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 45/100 | 60/100 |
| Traction | 35/100 | 53/100 |
| Team | 30/100 | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 14/100 | 23/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 10/100 | 20/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | iDEL Therapeutics | Infinimmune |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Google Analytics 4 |
iDEL Therapeutics vs Infinimmune: common questions
Which is better, iDEL Therapeutics or Infinimmune?
On our 0-100 score Infinimmune rates higher (60/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do iDEL Therapeutics and Infinimmune compare on the numbers?
Infinimmune leads on our overall score (60/100 against 45/100), agent readiness (42/100 against 32/100), domain rating (20/100 against 10/100), funding raised ($75.0M against $9.7M).
Read the full iDEL Therapeutics review and pricing or the Infinimmune review and pricing. You can also browse other iDEL Therapeutics alternatives we track.